share_log

Aveanna Healthcare Hldgs Analyst Ratings

Aveanna Healthcare Hldgs Analyst Ratings

Aveanna Healthcare Hold
Benzinga Analyst Ratings ·  2023/01/27 07:15
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
01/27/2023 -23.66% Credit Suisse $2 → $1 Downgrades Neutral → Underperform
11/21/2022 129.01% RBC Capital $7 → $3 Downgrades Outperform → Sector Perform
11/17/2022 52.67% Credit Suisse $5.5 → $2 Downgrades Outperform → Neutral
11/16/2022 205.34% Raymond James $6 → $4 Maintains Strong Buy
11/11/2022 14.5% Stephens & Co. $2.25 → $1.5 Maintains Equal-Weight
08/19/2022 281.68% Barclays $7 → $5 Maintains Overweight
08/15/2022 358.02% Raymond James $8 → $6 Maintains Strong Buy
07/22/2022 90.84% Jefferies $9 → $2.5 Downgrades Buy → Hold
07/05/2022 — Truist Securities Downgrades Buy → Hold
06/21/2022 167.18% Stephens & Co. $5.5 → $3.5 Downgrades Overweight → Equal-Weight
03/31/2022 510.69% Raymond James $12 → $8 Maintains Strong Buy
03/31/2022 587.02% RBC Capital $16 → $9 Maintains Outperform
03/30/2022 281.68% Truist Securities $10 → $5 Maintains Buy
03/30/2022 358.02% Deutsche Bank $12.5 → $6 Maintains Buy
03/30/2022 434.35% Stephens & Co. $11.5 → $7 Maintains Overweight
03/30/2022 434.35% Barclays $16 → $7 Maintains Overweight
03/30/2022 625.19% Credit Suisse $12 → $9.5 Maintains Outperform
03/29/2022 319.85% B of A Securities $10 → $5.5 Downgrades Buy → Neutral
11/23/2021 816.03% Raymond James $15 → $12 Maintains Strong Buy
05/24/2021 968.7% JP Morgan → $14 Initiates Coverage On → Neutral
05/24/2021 1045.04% Jefferies → $15 Initiates Coverage On → Buy
05/24/2021 1045.04% Raymond James → $15 Initiates Coverage On → Strong Buy
05/24/2021 930.53% Deutsche Bank → $13.5 Initiates Coverage On → Buy
05/24/2021 1121.37% Credit Suisse → $16 Initiates Coverage On → Outperform
05/24/2021 1197.71% BMO Capital → $17 Initiates Coverage On → Outperform
05/24/2021 1121.37% RBC Capital → $16 Initiates Coverage On → Outperform
05/24/2021 1426.72% Barclays → $20 Initiates Coverage On → Overweight
05/24/2021 1045.04% Truist Securities → $15 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
01/27/2023 -23.66% 瑞士信贷 $2 → $1 评级下调 中性→表现不佳
11/21/2022 129.01% 加拿大皇家银行资本 $7 → $3 评级下调 跑赢→板块表现
11/17/2022 52.67% 瑞士信贷 $5.5 → $2 评级下调 跑赢→中性
11/16/2022 205.34% 雷蒙德·詹姆斯 $6 → $4 维护 强势购买
11/11/2022 14.5% 斯蒂芬斯公司 $2.25 → $1.5 维护 等重
08/19/2022 281.68% 巴克莱 $7 → $5 维护 超重
08/15/2022 358.02% 雷蒙德·詹姆斯 $8 → $6 维护 强势购买
07/22/2022 90.84% 杰富瑞 $9 → $2.5 评级下调 购买→Hold
07/05/2022 — Truist证券 评级下调 购买→Hold
06/21/2022 167.18% 斯蒂芬斯公司 $5.5 → $3.5 评级下调 超重→等重
03/31/2022 510.69% 雷蒙德·詹姆斯 $12 → $8 维护 强势购买
03/31/2022 587.02% 加拿大皇家银行资本 $16 → $9 维护 跑赢大盘
03/30/2022 281.68% Truist证券 $10 → $5 维护 买
03/30/2022 358.02% 德意志银行 $12.5 → $6 维护 买
03/30/2022 434.35% 斯蒂芬斯公司 $11.5 → $7 维护 超重
03/30/2022 434.35% 巴克莱 $16 → $7 维护 超重
03/30/2022 625.19% 瑞士信贷 $12 → $9.5 维护 跑赢大盘
03/29/2022 319.85% B of A证券 $10 → $5.5 评级下调 购买→中性
11/23/2021 816.03% 雷蒙德·詹姆斯 $15 → $12 维护 强势购买
05/24/2021 968.7% 摩根大通 → $14 开始承保 →中性
05/24/2021 1045.04% 杰富瑞 → $15 开始承保 →购买
05/24/2021 1045.04% 雷蒙德·詹姆斯 → $15 开始承保 →强势购买
05/24/2021 930.53% 德意志银行 → $13.5 开始承保 →购买
05/24/2021 1121.37% 瑞士信贷 → $16 开始承保 →跑赢大盘
05/24/2021 1197.71% 蒙特利尔银行资本 → $17 开始承保 →跑赢大盘
05/24/2021 1121.37% 加拿大皇家银行资本 → $16 开始承保 →跑赢大盘
05/24/2021 1426.72% 巴克莱 → $20 开始承保 →超重
05/24/2021 1045.04% Truist证券 → $15 开始承保 →购买

What is the target price for Aveanna Healthcare Hldgs (AVAH)?

Aveanna Healthcare Hldgs(Avah)的目标价格是多少？

The latest price target for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was reported by Credit Suisse on January 27, 2023. The analyst firm set a price target for $1.00 expecting AVAH to fall to within 12 months (a possible -23.66% downside). 18 analyst firms have reported ratings in the last year.

瑞士信贷于2023年1月27日报告了Aveanna Healthcare Hldgs(纳斯达克：AVA)的最新目标价。这家分析公司将目标价定为1.00美元，预计Avah将在12个月内下跌(可能下跌23.66%)。去年有18家分析公司公布了评级。

What is the most recent analyst rating for Aveanna Healthcare Hldgs (AVAH)?

Aveanna Healthcare Hldgs(Avah)的最新分析师评级是多少？

The latest analyst rating for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was provided by Credit Suisse, and Aveanna Healthcare Hldgs downgraded their underperform rating.

瑞士信贷对Aveanna Healthcare Hldgs(纳斯达克代码：AVA)的最新分析师评级，Aveanna Healthcare Hldgs下调了其表现不佳的评级。

When is the next analyst rating going to be posted or updated for Aveanna Healthcare Hldgs (AVAH)?

Aveanna Healthcare Hldgs(Avah)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aveanna Healthcare Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aveanna Healthcare Hldgs was filed on January 27, 2023 so you should expect the next rating to be made available sometime around January 27, 2024.

分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Aveanna Healthcare Hldgs的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Aveanna Healthcare Hldgs的上一次评级是在2023年1月27日提交的，所以你应该预计下一次评级将在2024年1月27日左右的某个时候提供。

Is the Analyst Rating Aveanna Healthcare Hldgs (AVAH) correct?

分析师对Aveanna Healthcare Hldgs(Avah)的评级正确吗？

While ratings are subjective and will change, the latest Aveanna Healthcare Hldgs (AVAH) rating was a downgraded with a price target of $2.00 to $1.00. The current price Aveanna Healthcare Hldgs (AVAH) is trading at is $1.31, which is out of the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的Aveanna Healthcare Hldgs(Avah)评级被下调，目标价为2.00美元至1.00美元。Aveanna Healthcare Hldgs(Avah)目前的股价为1.31美元，超出了分析师的预测区间。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发